Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018
- 27 September 2021
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 150 (4) , 580-593
Abstract
When someone dies prematurely from cancer this represents a loss of productivity for society. This loss can be valued and provides a measure of the cancer burden. We estimated paid and unpaid productivity lost due to cancer‐related premature mortality in 31 European countries in 2018. Lost productivity was estimated for all cancers combined and 23 cancer sites, overall, by region and country. Deaths aged 15 to 64 were abstracted from GLOBOCAN 2018. Unpaid time lost (housework, caring, volunteering) was derived from Eurostat. Paid and unpaid productivity losses were valued using the human capital approach. In total, 347,149 premature cancer deaths occurred (60% male). The total value of cancer‐related lost productivity was €104.6 billion. Of this, €52.9 billion (50.6%) was due to lost paid work, and €51.7 billion (49.4%) to unpaid work. Females accounted for 36.7% of paid work costs but half (51.1%) of the unpaid work costs. Costs were highest in Western Europe (€52.0 billion). The most costly cancer was lung (€21.7 billion), followed by breast (€10.6 billion). The average loss per premature death was highest for Hodgkin's lymphoma (€506 345), melanoma (€450 694), brain cancer (€428 449) and leukaemia (€378 750). Cancer‐related lost productivity costs are significant. Almost half are due to unpaid work losses, indicating the importance of considering both paid and unpaid labour in assessing the cancer economic burden. The high cost per premature death of some less common cancers illustrates the potential benefits that could accrue from investment in prevention and control of these cancers.Keywords
This publication has 35 references indexed in Scilit:
- Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screeningEuropean Journal Of Cancer Prevention, 2015
- Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer‐related mortality in EuropeInternational Journal of Cancer, 2014
- The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burdenBMC Cancer, 2014
- How to Estimate Productivity Costs in Economic EvaluationsPharmacoEconomics, 2014
- Economic burden of cancer across the European Union: a population-based cost analysisThe Lancet Oncology, 2013
- Productivity Costs of Cancer Mortality in the United States: 2000–2020JNCI: Journal of the National Cancer Institute, 2008
- Economic valuation of informal care: Lessons from the application of the opportunity costs and proxy good methodsSocial Science & Medicine, 2006
- Economic valuation of informal careThe European Journal of Health Economics, 2004
- The friction cost method for measuring indirect costs of diseaseJournal of Health Economics, 1995
- On the Concept of Health Capital and the Demand for HealthJournal of Political Economy, 1972